Meta-Analysis: The Effect of D-Dimer on Mortality in Patients with COVID-19

Yusuf Ryadi, Setyo Sri Rahardjo, Burhannuddin Ichsan

Abstract

Background: The severity of COVID-19 can be detected by examining elevated levels of CRP, ferritin, IL-6 and LDH. Elevated D-dimer levels are often found in patients with severe COVID-19 which can predict the occurrence of ARDS (Acute Respiratory Distress Syndrome) and patient mortality. The purpose of this study was to determine how much influence D-dimer levels had on mortality of COVID-19 patients.
Subjects and Method: This study used a systematic review and meta-analysis with following PICO, population: patients with a clinical diagnosis of COVID-19. Intervention: high D-dimer level. Comparison: low D-dimer level. Outcome: mortality. The data used were obtained from scientific research articles from Pubmed, Google Scholar, Science Direct, and Proquest electronic databases with a cohort design in 2020 until 2022 and report on aOR in multivariate analysis. The keywords used in the search for scientific articles were “D-dimer level” OR “D-dimer” AND “COVID-19” AND “mortality”. The selection of articles is done by using PRISMA flow diagram. Data were analyzed using Review Manager software version 5.4.1.
Results: A total of 12 studies with a cohort design that met the criteria from Asia, America, and Europe were selected for a systematic review and meta-analysis. Based on the meta-analysis, it was found that increased levels of D-dimer (>0.5 g/mL) increased mortality in COVID-19 patients by 6.40 times compared to low levels of D-dimer (≤0.5 g/mL) and was statistically significant (aOR = 6.40; 95% CI= 4.51 to 9.08; p<0.001).
Conclusion: Elevated levels of D-dimer may increase mortality risk in COVID-19 patients.
Keywords: d-dimer level, d-dimer, covid-19, mortality.

Correspondence: Yusuf Ryadi. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36A, Surakarta 57126, Jawa Tengah. Email: yusuf.ryadi@gmail.com. Mobile: 085715605268


Journal of Epidemiology and Public Health (2022), 07(04): 552-561
https://doi.org/10.26911/jepublichealth.2022.07.04.11.

Full Text:

PDF

References

Berger JS, Kunichoff D, Adhikari (2020). Prevalence and Outcomes of D-Dimer Elevation in Hospitalized Patients with COVID-19. Arterioscler Thromb Vasc Biol. 40(10): 2539-2547. doi: 10.1161/ATVBAHA.120.314872.


Cao X (2020). COVID-19: immunepathology and its implications for therapy. Nat Rev Immunol. 395(20): 269-270. doi: 10.1038/s41577-020-0308-3.


Cui S, Chen S, Li X, Liu S, Wang F (2020). Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 18(6): 1421-1424. doi: 10.1111/jth.14830.


Du RH, Liang LR, Yang CQ, Wang W, Cao T, Li M, Guo G, et al. (2020). Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. doi: 10.1183/13993003.00524-2020.


Giacomelli A, Ridolfo AL, Milazzo L, Oreni L, Bernacchia D, Siano M, Bonazzetti C, et al. (2020). 30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epi-demic: A prospective cohort study. Pharmacol Res. doi:10.1016/j.phrs.2020.104931.


Gómez-Mesa JE, Galindo-Coral S, Montes MC, Muñoz MAJ (2021). Thrombosis and Coagulopathy in COVID-19. Curr Probl Cardiol. doi: 10.1016/j.cpcardiol.2020.100742.


Grobler C, Maphumulo SC, Grobbelaar LM (2020). Covid-19: The Rollercoaster of Fibrinogen, D-Dimer, Von Willebrand Factor, P-Selectin and Their Interactions with Endothelial Cells, Platelets and Erythrocytes. Int J Mol Sci. 14:5168. doi:10.3390/ijms21145168.


Hayiroglu MI, Cicek V, Kilic S, Cinar T (2021). Mean serum D-dimer level to predict in hospital mortality in Covid-19 patients. Eur Heart J. doi: 10.1093/eurheartj/ehab724.1514.


Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G (2020). Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 507: 167–173. doi: 10.1016/j.cca.2020.04.027.


Iba T, Levy JH, Levi M, Connors JM, Thachil J (2020). Coagulopathy of Coronavirus Disease 2019. Crit Care Med. 48(9): 2103–2109. doi: 10.1097/CCM.0000000000004458.


Levi M, Thachil J, Iba T, Levy JH (2020). Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 7(6): e438–e440. doi: 10.1016/S2352-3026(20)30145-9.


Li G, Fan Y, Lai Y (2020). Coronavirus infections and immune responses. J Virol. 92(4): 424-432 doi: 10.1002/jmv.25685.


Luo X, Xia H, Yang W, Wang B, Guo T, Xiong J, Jiang Z, Liu Y, Yan X, Zhou W, Ye L, Zhang B (2020). Characteristics of patients with COVID-19 during epidemic ongoing outbreak in Wuhan, China. medRxiv. doi: 10.1101/2020.03.19.20033175.


Mikami T, Miyashita H, Yamada T, Harrington M, Steinberg D, Dunn A, Siau E (2021). Risk Factors for Mortality in Patients with COVID-19 in New York City. J Gen Intern Med. doi: 10.1007/s11606-020-05983-z.


Milenkovic M, Hadzibegovic A, Kovac M, Jovanovic B, Stanisavljevic J, Djikic M, Sijan D, et al. (2022). D-dimer, CRP, PCT, and IL-6 Levels at Admission to ICU Can Predict In Hospital Mortality in Patients with COVID-19 Pneumonia. Oxid Med Cell Longev. doi: 10.1155/2022/8997709.


Nugroho J, Wardhana A, Maghfirah I, Mulia EPB, Rachmi DA, A'yun MQ, Septianda I (2021). Relationship of D-dimer with severity and mortality in SARS-CoV-2 patients: A meta-analysis. Int J Lab Hematol. doi: 10.1111/ijlh.13336.


Paranjpe I, Russak AJ, De Freitas JK, Lala A, Miotto R, Vaid A, Johnson KW, et al. (2020). Clinical Characteristics of Hospitalized Covid-19 Patients in New York City. medRxiv. doi: 10.1101/2020.04.19.20062117.


Pya Y, Bekbossynova M, Gaipov A, Lesbekov T, Kapyshev T, Kuanyshbek A, et al. (2021). Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan. PLoS ONE doi: 10.1371/journal.pone.0261272.


Terpos E, Kastritis E, Ntanasis-Stathopoulos I, Elalamy I, Sergentnis TN (2020). Hematological findings and complications of COVID-19. Am J Hematol. 95(7): 834-847. doi: 10.10-02/ajh.25829.


Tu WJ, Cao J, Yu L, Hu X, Liu Q (2020). Clinicolaboratory study of 25 fatal cases of COVID-19 in Wuhan. Intensive Care Med. doi: 10.1007/s00134-020-06023-4.


Wei Y, Zeng W, Huang X, Li J, Qui X, Li H, Liu D, et al. (2020). Clinical characteristics of 276 hospitalized patients with coronavirus disease 2019 in Zengdu District, Hubei Province: a single-center descriptive study. BMC Infect Dis. doi: 10.1186/s12879-020-05252-8.


Willim HA, Hardigaloeh AT, Supit AI. (2020). Koagulopati pada Coronavirus Disease -2019 (COVID-19): Tinjauan Pustaka. Intisari Sains Medis. 11:749-750.


Yao Y, Cao J, Wang Q, Shi Q, Liu K, Luo Z, Chen X, Chen S, Yu K, Huang Z, Hu B (2020). D-dimer as a biomarker for disease severity and mortality in COVID-19 patients. J Intensive Care. 8:49. doi: 10.1186/s40560-020-00466-z.


Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. doi: 10.1016/S0140-6736(20)30566-3.

Refbacks

  • There are currently no refbacks.